Kimberly Finn

Kim has extensive experience in the clinical trials industry with over 29 years of experience in roles within clinical operations and global project management in both pharma and CRO organizations. Kim’s expertise in clinical strategy has contributed to successful, on-time delivery of complex portfolios, resulting in numerous new drug application approvals. She has focused on decentralized trials for the last 8 years. As head of global patient centric services, kits and ancillary services, Kim oversees Marken’s global decentralized clinical trial strategy and operations.